aTyr Pharma ($ATYR) received 9 mentions across 12 months from three distinct FinTwit voices, with the first mention appearing on September 12, 2025. Adam Feuerstein (@adamfeuerstein) dominated discussion with 7 mentions, while InvestmentGuru (@investmentguru_) and Jacob Plieth (@jacobplieth) each contributed one mention. The biotech category drove all mentions of this ticker. Most recent activity focused on ATYR1923, the company's Phase 2 clinical candidate for interstitial lung disease, which operates through tRNA synthetase biology and carries orphan drug designation.